Fujifilm is helping make the world a better, healthier, and more interesting place. To learn more about what we’re about, please explore Innovation at the Fujifilm global website.
The holding company for U.S.-based Fujifilm companies operating in 27 states and engaged in the research, development, manufacture, sales and service of Fujifilm products. The company serves a broad spectrum of industries in the U.S. including medical and life sciences, electronic, chemical, graphic arts, information systems, motion picture, broadcast and photography.
Cellular Dynamics International's technology platform enables the production of high-quality, fully functional human cells, including induced pluripotent stem cells (iPSCs), on an industrial scale.
World’s leading supplier of drop-on-demand inkjet printheads for industrial applications.
An industry-leading Biologics Contract Manufacturing Organization with experience in the development and manufacturing of recombinant proteins, vaccines and monoclonal antibodies.
Supplier of advanced technology, chemistry and delivery equipment to the semiconductor and flat panel display fabrication market.
Worldwide leader in the invention, development and production of high performance colorants for the inkjet printing sector.
Comprised of five high technology manufacturing plants, the Greenwood Research Laboratories, and the largest Fujifilm distribution center in the world.
Leading provider of diagnostic imaging products and medical information solutions.
A marketing subsidiary of FUJIFILM Holdings America Corporation consists of five operating divisions and one subsidiary company.
Specializes in clinical research and development, and conducts research for development of new drugs that have unique therapeutic compounds desgined to combat illness.
US-based manufacturing, marketing and sales operations of professional broadcast video and data tape recording media.
SonoSite brings advanced ultrasound point-of-care technology to patients and institutions that would otherwise have no access to this imaging modality due to social conditions, remote locations, or lack of funds.